2025年4月28日晚间,药明康德发布了2025年一季度报告。根据报告显示,第一季度公司整体收入96.5亿元,同比增长21%;其中持续经营业务收入93.9亿元,同比增长23.1%。这也是药明康德历史上首次在一季度迈入90亿营收规模。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.